{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:03:20Z","timestamp":1790301800874,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.eplepsyres.2022.107066","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T20:14:39Z","timestamp":1671048879000},"page":"107066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Bioinformatics and network pharmacology analysis of drug targets and mechanisms related to the comorbidity of epilepsy and migraine"],"prefix":"10.1016","volume":"189","author":[{"given":"Ziyi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-2221","authenticated-orcid":false,"given":"Guohui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2022.107066_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11916-013-0351-x","article-title":"Headache and epilepsy","volume":"17","author":"Bauer","year":"2013","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2014.12.028","article-title":"Rescuable folding defective NaV1.1 (SCN1A) mutants in epilepsy: properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum","volume":"75","author":"Bechi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cns.13580","article-title":"The AMPAR antagonist perampanel protects the neurovascular unit against traumatic injury via regulating Sirt3","volume":"27","author":"Chen","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.celrep.2017.12.056","article-title":"PRRT2 regulates synaptic fusion by directly modulating SNARE complex assembly","volume":"22","author":"Coleman","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eplepsyres.2016.08.021","article-title":"Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies-An Italian observational multicenter study","volume":"127","author":"De Liso","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108391","article-title":"Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy","volume":"125","author":"Fernandes","year":"2021","journal-title":"Epilepsy Behav."},{"issue":"Suppl 1","key":"10.1016\/j.eplepsyres.2022.107066_bib7","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/j.eplepsyres.2006.01.019","article-title":"Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies","volume":"70","author":"Fujiwara","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1528-1167.2012.03528.x","article-title":"The somatic comorbidity of epilepsy: a weighty but often unrecognized burden","volume":"53","author":"Gaitatzis","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114152","article-title":"From spreading depolarization to epilepsy with neuroinflammation: the role of CGRP in cortex","volume":"356","author":"Gimeno-Ferrer","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib12","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1007\/s12035-021-02386-x","article-title":"Epilepsy and migraine shared genetic and molecular mechanisms: focus on therapeutic strategies","volume":"58","author":"Gotra","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib13","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1038\/s41598-022-12789-y","article-title":"Complex effects on CaV2.1 channel gating caused by a CACNA1A variant associated with a severe neurodevelopmental disorder","volume":"12","author":"Grosso","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.seizure.2021.03.028","article-title":"Epilepsy in patients with familial hemiplegic migraine","volume":"88","author":"Hasirci Bayir","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-981-13-1756-9_8","article-title":"Descending noradrenergic inhibition: an important mechanism of gabapentin analgesia in neuropathic pain","volume":"1099","author":"Hayashida","year":"2018","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yebeh.2017.09.014","article-title":"Epilepsy as a Network Disorder (1): what can we learn from other network disorders such as autistic spectrum disorder and mood disorders","volume":"77","author":"Kanner","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/ene.12612","article-title":"The comorbid relationship between migraine and epilepsy: a systematic review and meta-analysis","volume":"22","author":"Keezer","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s10194-021-01271-1","article-title":"Migraine and neuroinflammation: the inflammasome perspective","volume":"22","author":"Kursun","year":"2021","journal-title":"J. Headache Pain."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009239","article-title":"Modeling NaV1.1\/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine","volume":"17","author":"Lemaire","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s10194-021-01309-4","article-title":"Functional correlation of ATP1A2 mutations with phenotypic spectrum: from pure hemiplegic migraine to its variant forms","volume":"22","author":"Li","year":"2021","journal-title":"J. Headache Pain."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.gendis.2018.04.007","article-title":"Epilepsy and migraine-Are they comorbidity?","volume":"5","author":"Liao","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib24","article-title":"Common microRNAs in epilepsy and migraine: their possibility as candidates for biomarkers and therapeutic targets during comorbid onset of both conditions","author":"Ludhiadch","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib25","first-page":"2152399","article-title":"Pharmacological mechanisms of tinglizi against chronic heart failure determined by network pharmacology and molecular docking","volume":"2022","author":"Luo","year":"2022","journal-title":"Evid. Based Complement Altern. Med"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s11356-022-21878-4","article-title":"Topiramate potential neurotoxicity and mitigating role of ginger oil in mice brain","author":"Mabrouk","year":"2022","journal-title":"Environ. Sci. Pollut. Res Int"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/FPC.0000000000000397","article-title":"PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics","volume":"30","author":"Mitra-Ghosh","year":"2020","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib28","first-page":"17","article-title":"Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference","volume":"6","author":"Naegel","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/head.12536","article-title":"Migraine and epilepsy: review of the literature","volume":"55","author":"Nye","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1528-1167.2010.02927.x","article-title":"Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey","volume":"52","author":"Ottman","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib31","article-title":"Measures to mitigate sodium valproate use in pregnant women with epilepsy","volume":"14","author":"Ranjith","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1684\/epd.2021.1266","article-title":"Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation","volume":"23","author":"Riva","year":"2021","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yebeh.2016.12.005","article-title":"Correlates of quality of life among individuals with epilepsy enrolled in self-management research: from the US Centers for Disease Control and Prevention Managing Epilepsy Well Network","volume":"69","author":"Sajatovic","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-022-03003-6","article-title":"A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG","author":"Shi","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yebeh.2016.11.018","article-title":"Epilepsy treatment in adults and adolescents: expert opinion, 2016","volume":"69","author":"Shih","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib36","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.21037\/apm-19-690","article-title":"A conjoint analysis of epilepsy and migraine through network-and-pathway-based method","volume":"9","author":"Shu","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pedhc.2005.10.014","article-title":"Epilepsy and migraine headache: is there a connection","volume":"20","author":"Stevenson","year":"2006","journal-title":"J. Pedia Health Care"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.644047","article-title":"Deciphering in silico the role of mutated Na V 1.1 sodium channels in enhancing trigeminal nociception in familial hemiplegic migraine type 3","volume":"15","author":"Suleimanova","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s10194-018-0940-5","article-title":"Perampanel inhibits calcitonin gene-related peptide release from rat brainstem in vitro","volume":"19","author":"Tringali","year":"2018","journal-title":"J. Headache Pain."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eplepsyres.2013.12.013","article-title":"Comorbidity between headache and epilepsy in a Chinese epileptic center","volume":"108","author":"Wang","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/epi.12072","article-title":"Evidence for a shared genetic susceptibility to migraine and epilepsy","volume":"54","author":"Winawer","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117063","article-title":"Molecular mechanism of celastrol in the treatment of systemic lupus erythematosus based on network pharmacology and molecular docking technology","volume":"240","author":"Xinqiang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113751","article-title":"Gastrodin alleviates seizure severity and neuronal excitotoxicities in the rat lithium-pilocarpine model of temporal lobe epilepsy via enhancing GABAergic transmission","volume":"269","author":"Yang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.eplepsyres.2022.107066_bib44","first-page":"3003","article-title":"Gabapentin inhibits central sensitization during migraine","volume":"8","author":"Zhang","year":"2013","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.eplepsyres.2022.107066_bib45","first-page":"5436","article-title":"Prediction of active ingredients and mechanism of Siwei Jianbu decoction in the treatment of atherosclerosis by network pharmacology","volume":"26","author":"Li","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:49:26Z","timestamp":1760276966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121122002170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"alternative-id":["S0920121122002170"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.107066","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioinformatics and network pharmacology analysis of drug targets and mechanisms related to the comorbidity of epilepsy and migraine","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.107066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107066"}}